Working… Menu
Trial record 84 of 1333 for:    Hematologic neoplasm

Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT (CMV_TCR-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02988258
Recruitment Status : Suspended (Protocol being re-written to allow inclusion of more patients)
First Posted : December 9, 2016
Last Update Posted : September 12, 2018
Information provided by (Responsible Party):
University College, London

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : August 2019
Estimated Study Completion Date : August 2019